- Home
- GSK vs MMM Comparison
GSK vs MMM Comparison
Compare GSK & MMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GSK
- MMM
- Stock Information
- Founded
- GSK 1715
- MMM 1902
- Country
- GSK United Kingdom
- MMM United States
- Employees
- GSK N/A
- MMM N/A
- Industry
- GSK Biotechnology: Pharmaceutical Preparations
- MMM Medical/Dental Instruments
- Sector
- GSK Health Care
- MMM Health Care
- Exchange
- GSK Nasdaq
- MMM Nasdaq
- Market Cap
- GSK 76.5B
- MMM 71.9B
- IPO Year
- GSK N/A
- MMM N/A
- Fundamental
- Price
- GSK $33.33
- MMM $128.36
- Analyst Decision
- GSK Hold
- MMM Buy
- Analyst Count
- GSK 5
- MMM 15
- Target Price
- GSK $45.50
- MMM $144.87
- AVG Volume (30 Days)
- GSK 8.2M
- MMM 3.3M
- Earning Date
- GSK 10-30-2024
- MMM 10-22-2024
- Dividend Yield
- GSK 4.67%
- MMM 2.19%
- EPS Growth
- GSK N/A
- MMM N/A
- EPS
- GSK 0.81
- MMM 7.92
- Revenue
- GSK $41,966,224,352.00
- MMM $32,638,000,000.00
- Revenue This Year
- GSK $6.50
- MMM N/A
- Revenue Next Year
- GSK $4.54
- MMM $2.93
- P/E Ratio
- GSK $20.03
- MMM $16.15
- Revenue Growth
- GSK 5.59
- MMM 22.30
- 52 Week Low
- GSK $32.83
- MMM $75.65
- 52 Week High
- GSK $45.93
- MMM $141.34
- Technical
- Relative Strength Index (RSI)
- GSK 24.28
- MMM 41.26
- Support Level
- GSK $33.19
- MMM $128.47
- Resistance Level
- GSK $33.79
- MMM $133.31
- Average True Range (ATR)
- GSK 0.48
- MMM 2.40
- MACD
- GSK -0.19
- MMM -0.27
- Stochastic Oscillator
- GSK 11.63
- MMM 21.22
About GSK GSK plc (Each representing two)
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, antiviral, and vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
About MMM 3M Company
3M, a multinational conglomerate founded in 1902, sells tens of thousands of products ranging from sponges to respirators. The firm is well known for its extensive research and development capabilities, and it is a pioneer in inventing new use cases for its proprietary technologies. 3M is organized across three business segments: safety and industrial (representing around 44% of revenue), transportation and electronics (36%), and consumer (20%). The firm recently spun off its healthcare business, now known as Solventum. Nearly half of 3M's revenue comes from outside the Americas.